大麻酚
内大麻素系统
合法化
大麻
药理学
娱乐性毒品
娱乐
食品药品监督管理局
医学
人口
药品
大麻素
精神科
政治学
受体
环境卫生
内科学
法学
作者
Mauro Maccarrone,Vincenzo Di Marzo,Jürg Gertsch,Uwe Grether,Allyn C. Howlett,Tian Hua,Alexandros Makriyannis,Daniele Piomelli,Natsuo Ueda,Mario van der Stelt
出处
期刊:Pharmacological Reviews
[American Society for Pharmacology & Experimental Therapeutics]
日期:2023-05-10
卷期号:75 (5): 885-958
被引量:95
标识
DOI:10.1124/pharmrev.122.000600
摘要
The cannabis derivative marijuana is the most widely used recreational drug in the Western world and is consumed by an estimated 83 million individuals (∼3% of the world population). In recent years, there has been a marked transformation in society regarding the risk perception of cannabis, driven by its legalization and medical use in many states in the United States and worldwide. Compelling research evidence and the Food and Drug Administration cannabis-derived cannabidiol approval for severe childhood epilepsy have confirmed the large therapeutic potential of cannabidiol itself, Δ
科研通智能强力驱动
Strongly Powered by AbleSci AI